215 related articles for article (PubMed ID: 29278865)
1. Simvastatin activates single skeletal RyR1 channels but exerts more complex regulation of the cardiac RyR2 isoform.
Venturi E; Lindsay C; Lotteau S; Yang Z; Steer E; Witschas K; Wilson AD; Wickens JR; Russell AJ; Steele D; Calaghan S; Sitsapesan R
Br J Pharmacol; 2018 Mar; 175(6):938-952. PubMed ID: 29278865
[TBL] [Abstract][Full Text] [Related]
2. Statin activation of skeletal ryanodine receptors (RyR1) is a class effect but separable from HMG-CoA reductase inhibition.
Lindsay C; Musgaard M; Russell AJ; Sitsapesan R
Br J Pharmacol; 2022 Nov; 179(21):4941-4957. PubMed ID: 35703154
[TBL] [Abstract][Full Text] [Related]
3. Halothane modulation of skeletal muscle ryanodine receptors: dependence on Ca2+, Mg2+, and ATP.
Diaz-Sylvester PL; Porta M; Copello JA
Am J Physiol Cell Physiol; 2008 Apr; 294(4):C1103-12. PubMed ID: 18305228
[TBL] [Abstract][Full Text] [Related]
4. Amitriptyline activates cardiac ryanodine channels and causes spontaneous sarcoplasmic reticulum calcium release.
Chopra N; Laver D; Davies SS; Knollmann BC
Mol Pharmacol; 2009 Jan; 75(1):183-95. PubMed ID: 18845675
[TBL] [Abstract][Full Text] [Related]
5. Differential Ca(2+) sensitivity of skeletal and cardiac muscle ryanodine receptors in the presence of calmodulin.
Fruen BR; Bardy JM; Byrem TM; Strasburg GM; Louis CF
Am J Physiol Cell Physiol; 2000 Sep; 279(3):C724-33. PubMed ID: 10942723
[TBL] [Abstract][Full Text] [Related]
6. Ca(2+)-calmodulin can activate and inactivate cardiac ryanodine receptors.
Sigalas C; Bent S; Kitmitto A; O'Neill S; Sitsapesan R
Br J Pharmacol; 2009 Mar; 156(5):794-806. PubMed ID: 19220289
[TBL] [Abstract][Full Text] [Related]
7. FKBP12 activates the cardiac ryanodine receptor Ca2+-release channel and is antagonised by FKBP12.6.
Galfré E; Pitt SJ; Venturi E; Sitsapesan M; Zaccai NR; Tsaneva-Atanasova K; O'Neill S; Sitsapesan R
PLoS One; 2012; 7(2):e31956. PubMed ID: 22363773
[TBL] [Abstract][Full Text] [Related]
8. Ryanodine modification of RyR1 retrogradely affects L-type Ca(2+) channel gating in skeletal muscle.
Bannister RA; Beam KG
J Muscle Res Cell Motil; 2009; 30(5-6):217-23. PubMed ID: 19802526
[TBL] [Abstract][Full Text] [Related]
9. Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass.
Hilliard FA; Steele DS; Laver D; Yang Z; Le Marchand SJ; Chopra N; Piston DW; Huke S; Knollmann BC
J Mol Cell Cardiol; 2010 Feb; 48(2):293-301. PubMed ID: 19835880
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated Zn
Reilly-O'Donnell B; Robertson GB; Karumbi A; McIntyre C; Bal W; Nishi M; Takeshima H; Stewart AJ; Pitt SJ
J Biol Chem; 2017 Aug; 292(32):13361-13373. PubMed ID: 28630041
[TBL] [Abstract][Full Text] [Related]
11. Skeletal and cardiac ryanodine receptors exhibit different responses to Ca2+ overload and luminal ca2+.
Kong H; Wang R; Chen W; Zhang L; Chen K; Shimoni Y; Duff HJ; Chen SR
Biophys J; 2007 Apr; 92(8):2757-70. PubMed ID: 17259277
[TBL] [Abstract][Full Text] [Related]
12. Muscle weakness in Ryr1I4895T/WT knock-in mice as a result of reduced ryanodine receptor Ca2+ ion permeation and release from the sarcoplasmic reticulum.
Loy RE; Orynbayev M; Xu L; Andronache Z; Apostol S; Zvaritch E; MacLennan DH; Meissner G; Melzer W; Dirksen RT
J Gen Physiol; 2011 Jan; 137(1):43-57. PubMed ID: 21149547
[TBL] [Abstract][Full Text] [Related]
13. Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation.
Sedej S; Heinzel FR; Walther S; Dybkova N; Wakula P; Groborz J; Gronau P; Maier LS; Vos MA; Lai FA; Napolitano C; Priori SG; Kockskämper J; Pieske B
Cardiovasc Res; 2010 Jul; 87(1):50-9. PubMed ID: 20080988
[TBL] [Abstract][Full Text] [Related]
14. Tectoridins modulate skeletal and cardiac muscle sarcoplasmic reticulum calcium-release channels.
Bidasee KR; Maxwell A; Reynolds WF; Patel V; Besch HR
J Pharmacol Exp Ther; 2000 Jun; 293(3):1074-83. PubMed ID: 10869412
[TBL] [Abstract][Full Text] [Related]
15. R4496C RyR2 mutation impairs atrial and ventricular contractility.
Ferrantini C; Coppini R; Scellini B; Ferrara C; Pioner JM; Mazzoni L; Priori S; Cerbai E; Tesi C; Poggesi C
J Gen Physiol; 2016 Jan; 147(1):39-52. PubMed ID: 26666913
[TBL] [Abstract][Full Text] [Related]
16. Dampened activity of ryanodine receptor channels in mutant skeletal muscle lacking TRIC-A.
El-Ajouz S; Venturi E; Witschas K; Beech M; Wilson AD; Lindsay C; Eberhardt D; O'Brien F; Iida T; Nishi M; Takeshima H; Sitsapesan R
J Physiol; 2017 Jul; 595(14):4769-4784. PubMed ID: 28387457
[TBL] [Abstract][Full Text] [Related]
17. Unique isoform-specific properties of calsequestrin in the heart and skeletal muscle.
Wei L; Hanna AD; Beard NA; Dulhunty AF
Cell Calcium; 2009 May; 45(5):474-84. PubMed ID: 19376574
[TBL] [Abstract][Full Text] [Related]
18. Ca(2+) inactivation sites are located in the COOH-terminal quarter of recombinant rabbit skeletal muscle Ca(2+) release channels (ryanodine receptors).
Du GG; MacLennan DH
J Biol Chem; 1999 Sep; 274(37):26120-6. PubMed ID: 10473562
[TBL] [Abstract][Full Text] [Related]
19. K201 (JTV519) is a Ca2+-Dependent Blocker of SERCA and a Partial Agonist of Ryanodine Receptors in Striated Muscle.
Darcy YL; Diaz-Sylvester PL; Copello JA
Mol Pharmacol; 2016 Aug; 90(2):106-15. PubMed ID: 27235390
[TBL] [Abstract][Full Text] [Related]
20. Multiple regions of RyR1 mediate functional and structural interactions with alpha(1S)-dihydropyridine receptors in skeletal muscle.
Protasi F; Paolini C; Nakai J; Beam KG; Franzini-Armstrong C; Allen PD
Biophys J; 2002 Dec; 83(6):3230-44. PubMed ID: 12496092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
